These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 23499431)

  • 1. Exploring the accessible conformations of N-terminal acetylated α-synuclein.
    Moriarty GM; Janowska MK; Kang L; Baum J
    FEBS Lett; 2013 Apr; 587(8):1128-38. PubMed ID: 23499431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence.
    Kang L; Janowska MK; Moriarty GM; Baum J
    PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.
    Watson MD; Lee JC
    Biochemistry; 2019 Sep; 58(35):3630-3633. PubMed ID: 31424918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein.
    Atieh TB; Roth J; Yang X; Hoop CL; Baum J
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer.
    Kang L; Moriarty GM; Woods LA; Ashcroft AE; Radford SE; Baum J
    Protein Sci; 2012 Jul; 21(7):911-7. PubMed ID: 22573613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
    Jiang C; Chang JY
    Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.
    Sekiya H; Tsuji A; Hashimoto Y; Takata M; Koga S; Nishida K; Futamura N; Kawamoto M; Kohara N; Dickson DW; Kowa H; Toda T
    Acta Neuropathol Commun; 2022 Sep; 10(1):133. PubMed ID: 36068646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.
    Gerez JA; Prymaczok NC; Rockenstein E; Herrmann US; Schwarz P; Adame A; Enchev RI; Courtheoux T; Boersema PJ; Riek R; Peter M; Aguzzi A; Masliah E; Picotti P
    Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamical Behavior of Human α-Synuclein Studied by Quasielastic Neutron Scattering.
    Fujiwara S; Araki K; Matsuo T; Yagi H; Yamada T; Shibata K; Mochizuki H
    PLoS One; 2016; 11(4):e0151447. PubMed ID: 27097022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Α-synuclein misfolding and Parkinson's disease.
    Breydo L; Wu JW; Uversky VN
    Biochim Biophys Acta; 2012 Feb; 1822(2):261-85. PubMed ID: 22024360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the native state of α-synuclein.
    Selkoe D; Dettmer U; Luth E; Kim N; Newman A; Bartels T
    Neurodegener Dis; 2014; 13(2-3):114-7. PubMed ID: 24192542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-Molecule-Induced Soluble Oligomers of α-Synuclein with Helical Structure.
    Fonseca-Ornelas L; Schmidt C; Camacho-Zarco AR; Fernandez CO; Becker S; Zweckstetter M
    Chemistry; 2017 Sep; 23(53):13010-13014. PubMed ID: 28763125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
    García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
    Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
    Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
    Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
    PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.
    Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S
    Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and pathological properties of alpha-synuclein.
    Tofaris GK; Spillantini MG
    Cell Mol Life Sci; 2007 Sep; 64(17):2194-201. PubMed ID: 17605001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.